Trk receptor tyrosine kinases: A bridge between cancer and neural development

被引:379
作者
Nakagawara, A [1 ]
机构
[1] Chiba Canc Ctr Res Inst, Div Biochem, Chuoh Ku, Chiba 2608717, Japan
关键词
Trk receptor tyrosine kinases; protooncogene; neuroblastoma;
D O I
10.1016/S0304-3835(01)00530-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The proto-oncogene Trks encode the high-affinity receptor tyrosine kinases for neurotrophins of a nerve growth factor (NGF) family. The Trk signals spatiotemporally regulate neural development and maintenance of neural network. However, Trk was originally cloned as an oncogene fused with the tropomyosin gene in the extracellular domain. Accumulating evidence has demonstrated that the rearranged Trk oncogene is often observed in non-neuronal neoplasms such as colon and papillary thyroid cancers, while the signals through the receptors encoded by the proto-oncogene Trks regulate growth, differentiation and apoptosis of the tumors with neuronal origin such as neuroblastoma and medulloblastoma. The intracellular Trk signaling pathway is also different depending on the Trk family receptors, cell types and the grade of transformation. Furthermore, developmentally programmed cell death of neuron, which is largely regulated by neurotrophin signaling, is at least in part controlled by tumor suppressors p53 and p73 as well as their antagonist Delta Np73. Thus, the Trks and their downstream signaling function in both ontogenesis and oncogenesis. In this short review, the dynamic role of the Trk family receptors signaling in neural development, neurogenic tumors and other cancers will be discussed. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:107 / 114
页数:8
相关论文
共 42 条
  • [31] An anti-apoptotic role for the p53 family member, p73, during developmental neuron death
    Pozniak, CD
    Radinovic, S
    Yang, A
    McKeon, F
    Kaplan, DR
    Miller, FD
    [J]. SCIENCE, 2000, 289 (5477) : 304 - 306
  • [32] Identification and characterization of an activating TrkA deletion mutation in acute myeloid leukemia
    Reuther, GW
    Lambert, QT
    Caligiuri, MA
    Der, CJ
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (23) : 8655 - 8666
  • [33] Opposing effects of Ras on p53:: Transcriptional activation of mdm2 and induction of p19ARF
    Ries, S
    Biederer, C
    Woods, D
    Shifman, O
    Shirasawa, S
    Sasazuki, T
    McMahon, M
    Oren, M
    McCormick, F
    [J]. CELL, 2000, 103 (02) : 321 - 330
  • [34] EXPRESSION OF THE NEUROTROPHIN RECEPTOR TRKC IS LINKED TO A FAVORABLE OUTCOME IN MEDULLOBLASTOMA
    SEGAL, RA
    GOUMNEROVA, LC
    KWON, YK
    STILES, CD
    POMEROY, SL
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (26) : 12867 - 12871
  • [35] FUNCTIONS OF THE NEUROTROPHINS DURING NERVOUS-SYSTEM DEVELOPMENT - WHAT THE KNOCKOUTS ARE TEACHING US
    SNIDER, WD
    [J]. CELL, 1994, 77 (05) : 627 - 638
  • [36] LACK OF HIGH-AFFINITY NERVE GROWTH-FACTOR RECEPTORS IN AGGRESSIVE NEUROBLASTOMAS
    SUZUKI, T
    BOGENMANN, E
    SHIMADA, H
    STRAM, D
    SEEGER, RC
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) : 377 - 384
  • [37] Nerve growth factor cooperates with p185HER2 in activating growth of human breast carcinoma cells
    Tagliabue, E
    Castiglioni, F
    Ghirelli, C
    Modugno, M
    Asnaghi, L
    Somenzi, G
    Melani, C
    Ménard, S
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (08) : 5388 - 5394
  • [38] Urdiales JL, 1998, J NEUROSCI, V18, P6767
  • [39] Surfing the p53 network
    Vogelstein, B
    Lane, D
    Levine, AJ
    [J]. NATURE, 2000, 408 (6810) : 307 - 310
  • [40] Yamashiro DJ, 1996, ONCOGENE, V12, P37